Daily Sabah logo

Politics
Diplomacy Legislation War On Terror EU Affairs Elections News Analysis
TÜRKİYE
Istanbul Education Investigations Minorities Expat Corner Diaspora
World
Mid-East Europe Americas Asia Pacific Africa Syrian Crisis Islamophobia
Business
Automotive Economy Energy Finance Tourism Tech Defense Transportation News Analysis
Lifestyle
Health Environment Travel Food Fashion Science Religion History Feature Expat Corner
Arts
Cinema Music Events Portrait Reviews Performing Arts
Sports
Football Basketball Motorsports Tennis
Opinion
Columns Op-Ed Reader's Corner Editorial
PHOTO GALLERY
JOBS ABOUT US RSS PRIVACY CONTACT US
© Turkuvaz Haberleşme ve Yayıncılık 2025

Daily Sabah - Latest & Breaking News from Turkey | Istanbul

  • Politics
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • Elections
    • News Analysis
  • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Expat Corner
    • Diaspora
  • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • Islamophobia
  • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
  • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
  • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Reviews
    • Performing Arts
  • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
  • Gallery
  • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
  • TV
  • Life
  • Health
  • Environment
  • Travel
  • Food
  • Fashion
  • Science
  • Religion
  • History
  • Feature
  • Expat Corner

BioNTech’s trio earns Germany’s top medical research prize

by Agencies

ISTANBUL Sep 21, 2021 - 1:40 pm GMT+3
Özlem Türeci (L) and Uğur Şahin sit in the front row in Cologne, Germany, Sept. 17, 2021. (AP Photo)
Özlem Türeci (L) and Uğur Şahin sit in the front row in Cologne, Germany, Sept. 17, 2021. (AP Photo)
by Agencies Sep 21, 2021 1:40 pm

The founders and a biochemist of German BioNTech, who developed a vaccine against COVID-19 with messenger RNA (mRNA) technology, won the country's most prestigious medical research prize.

The Paul Ehrlich and Ludwig Darmstaedter Prize will be awarded to BioNTech's founders, Özlem Türeci and Uğur Şahin, and the biochemist Katalin Kariko, who joined the company in 2013.

The three laureates will receive the award "for their research and development of messenger RNA for preventive and therapeutic purposes," the foundation board in Frankfurt announced Tuesday.

BioNTech's vaccine was the first to be approved for use across Europe. Furthermore, while the rollout of several other vaccines was halted due to concerns over rare side effects, BioNTech faced no such issues.

The laureates had established a technology "that is likely to introduce a paradigm shift in some areas of medicine," the foundation said.

The "spectacularly fast" development of a highly effective vaccine against COVID-19 was praised by the jury as an "outstanding success."

Many winners of the Paul Ehrlich prize in past decades have gone on to receive the Nobel Prize in medicine. The honor has been awarded since 1952. The prize is traditionally presented on the birthday of Nobel Prize winner Paul Ehrlich, on March 14.

Last year, Şahin, who is BioNTech's CEO, announced positive results from the Phase 3 trials and expressed hope that their efforts would help bring an end to the global health crisis. Since the first announcement, which said the jab provided 90% protection against COVID-19, the rate has increased to 95%.

In March, Şahin and Türeci also received Germany's highest award, the Knight Commander's Cross of Order of Merit for their work on the vaccine. They were also named "People of the Year" by Financial Times last year.

Both Şahin and Türeci were born to immigrant parents from Turkey who moved to Germany in the 1960s.

Şahin, who was born in Iskenderun, Turkey, in 1965, arrived in Germany as a 4-year-old, where his father worked in a car factory. He studied medicine at the University of Cologne and worked for several years at Saarland University Medical Center.

Türeci is the daughter of a Turkish physician, who emigrated to Germany from Istanbul. She studied medicine at the Saarland University Faculty of Medicine and become a pioneer of cancer immunotherapy in Germany.

  • shortlink copied
  • KEYWORDS
    coronavirus vaccine biontech mrna uğur şahin özlem türeci covid-19 pandemic
    The Daily Sabah Newsletter
    Keep up to date with what’s happening in Turkey, it’s region and the world.
    You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    No Image
    9/11: Images of the worst terrorist attack on US soil
    PHOTOGALLERY
    • POLITICS
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • News Analysis
    • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Diaspora
    • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • İslamophobia
    • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
    • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
    • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Performing Arts
    • Reviews
    • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
    • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
    • Photo gallery
    • DS TV
    • Jobs
    • privacy
    • about us
    • contact us
    • RSS
    © Turkuvaz Haberleşme ve Yayıncılık 2021